In hepatoblastoma, METTL3 is identified as a direct target of hsa-miR-186, and the hsa-miR-186/METTL3 axis participates in the progress of hepatoblastoma through the Wnt/β-catenin signaling pathway (26). The gene discussed is METTL3; the disease is hepatoblastoma.